These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3923812)

  • 1. Today's pharmaceuticals: a cost-effective investment.
    Hoffmeister TW
    Am Pharm; 1985 May; NS25(5):4-6. PubMed ID: 3923812
    [No Abstract]   [Full Text] [Related]  

  • 2. Special report: the value of pharmaceuticals. An "expensive" drug may be the most cost effective.
    Siegelman S
    Bus Health; 1991; [VALUE]():8-14. PubMed ID: 10170908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-cutting ideas: prescription drugs.
    Fish JL
    J Health Care Benefits; 1993; 3(1):10-3. PubMed ID: 10130342
    [No Abstract]   [Full Text] [Related]  

  • 4. Providing cost-effective therapy using pharmacoeconomic evaluations: the public sector approach.
    Finder S
    Clin Ther; 1997; 19(1):160-6. PubMed ID: 9182021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: a high value target for cost containment.
    Gomella LG
    Can J Urol; 2013 Oct; 20(5):6888. PubMed ID: 24128823
    [No Abstract]   [Full Text] [Related]  

  • 6. How pharmaceuticals cut direct & indirect costs of therapy.
    Levy RA
    Pharm Times; 1985 Dec; 51(12):82-8. PubMed ID: 10311420
    [No Abstract]   [Full Text] [Related]  

  • 7. The elderly, drugs, and cost control.
    Lamy PP
    Drug Intell Clin Pharm; 1982 Oct; 16(10):768-71. PubMed ID: 6754322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed care cost effectiveness: fantasy or reality?
    Mone LC
    Int J Group Psychother; 1994 Oct; 44(4):437-48. PubMed ID: 7843843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pharmaceuticals reduce cost of illness.
    Hansen RW
    CPJ; 1986 Jun; 119(6):318-20, 323-5. PubMed ID: 10311615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication restrictions: feeling the side effects.
    Fitzpatrick C
    Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effective drug therapy.
    McGhan WF
    Healthc Exec; 1993; 8(4):27. PubMed ID: 10126748
    [No Abstract]   [Full Text] [Related]  

  • 12. Balancing cost and quality: methods of evaluation.
    Russell LB
    Bull N Y Acad Med; 1986; 62(1):55-60. PubMed ID: 3082396
    [No Abstract]   [Full Text] [Related]  

  • 13. Information systems for cost-effective management.
    DiMauro ME
    Top Health Care Financ; 1987; 14(2):28-34. PubMed ID: 3122365
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost effectiveness of drug therapy.
    Lipman AG
    Hosp Formul; 1984 Oct; 19(10):875. PubMed ID: 10310819
    [No Abstract]   [Full Text] [Related]  

  • 15. Making "me-too" drugs benefit the public.
    Nusbaum NJ
    Am J Med Qual; 2002; 17(6):215-7. PubMed ID: 12487336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How effective are medicines in containing health-care costs?
    Pharm Times; 1982 Aug; 48(8):38-40. PubMed ID: 10257236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bitter pills for insurance patients].
    Lüth P
    Fortschr Med; 1983 Oct; 101(37):1643-4. PubMed ID: 6642374
    [No Abstract]   [Full Text] [Related]  

  • 18. Health status and pharmaceutical programs: from cost minimization to cost-utility analysis.
    Pathak DS; Reardon G
    Top Hosp Pharm Manage; 1988 Nov; 8(3):66-77. PubMed ID: 10314316
    [No Abstract]   [Full Text] [Related]  

  • 19. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of information systems in the hospital--physician relationship.
    Green JM
    Top Health Care Financ; 1987; 14(2):9-16. PubMed ID: 3122366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.